<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>GLP-1 & Tirzepatide Clinical Reference</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        :root {
            --emergency-red: #dc2626;
            --emergency-bg: #fef2f2;
            --emergency-border: #fecaca;
            --warning-orange: #ea580c;
            --warning-bg: #fff7ed;
            --warning-border: #fed7aa;
            --safe-green: #16a34a;
            --safe-bg: #f0fdf4;
            --safe-border: #bbf7d0;
            --info-blue: #0284c7;
            --info-bg: #f0f9ff;
            --info-border: #bae6fd;
            --neutral-gray: #475569;
            --neutral-bg: #f8fafc;
            --neutral-border: #e2e8f0;
            --text-primary: #1e293b;
            --text-secondary: #64748b;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            background: #f1f5f9;
            color: var(--text-primary);
            line-height: 1.6;
            padding: 20px;
            min-height: 100vh;
        }

        .container {
            max-width: 1400px;
            margin: 0 auto;
        }

        /* Header */
        .header {
            background: linear-gradient(135deg, var(--info-blue) 0%, #0369a1 100%);
            color: white;
            padding: 24px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            box-shadow: 0 4px 20px rgba(2, 132, 199, 0.3);
        }

        .header h1 {
            font-size: 28px;
            font-weight: 700;
            margin-bottom: 8px;
        }

        .header p {
            opacity: 0.9;
            font-size: 14px;
        }

        /* Navigation */
        .nav-tabs {
            display: flex;
            gap: 8px;
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .nav-tab {
            padding: 12px 24px;
            background: white;
            border: 2px solid var(--neutral-border);
            border-radius: 12px;
            cursor: pointer;
            font-weight: 600;
            font-size: 14px;
            color: var(--text-secondary);
            transition: all 0.3s ease;
        }

        .nav-tab:hover {
            border-color: var(--info-blue);
            color: var(--info-blue);
            transform: translateY(-2px);
        }

        .nav-tab.active {
            background: var(--info-blue);
            color: white;
            border-color: var(--info-blue);
        }

        /* Card Styles */
        .card {
            background: white;
            border-radius: 16px;
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
            transition: all 0.3s ease;
            border: 1px solid var(--neutral-border);
        }

        .card:hover {
            box-shadow: 0 8px 24px rgba(0, 0, 0, 0.1);
            transform: translateY(-2px);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 16px;
            border-bottom: 1px solid var(--neutral-border);
        }

        .card-header h2 {
            font-size: 18px;
            font-weight: 700;
            color: var(--text-primary);
        }

        .card-header .icon {
            width: 40px;
            height: 40px;
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 20px;
        }

        /* Emergency Banner */
        .emergency-banner {
            background: var(--emergency-bg);
            border: 2px solid var(--emergency-red);
            border-radius: 12px;
            padding: 20px;
            margin-bottom: 20px;
            animation: pulse-red 2s infinite;
        }

        @keyframes pulse-red {
            0%, 100% { box-shadow: 0 0 0 0 rgba(220, 38, 38, 0.4); }
            50% { box-shadow: 0 0 0 8px rgba(220, 38, 38, 0); }
        }

        .emergency-banner h3 {
            color: var(--emergency-red);
            font-size: 16px;
            font-weight: 700;
            display: flex;
            align-items: center;
            gap: 8px;
            margin-bottom: 12px;
        }

        .emergency-banner ul {
            margin-left: 24px;
            color: var(--text-primary);
        }

        .emergency-banner li {
            margin-bottom: 8px;
        }

        /* Warning Banner */
        .warning-banner {
            background: var(--warning-bg);
            border: 2px solid var(--warning-orange);
            border-radius: 12px;
            padding: 16px 20px;
            margin-bottom: 20px;
        }

        .warning-banner h4 {
            color: var(--warning-orange);
            font-size: 14px;
            font-weight: 700;
            display: flex;
            align-items: center;
            gap: 8px;
            margin-bottom: 8px;
        }

        /* Safe Banner */
        .safe-banner {
            background: var(--safe-bg);
            border: 2px solid var(--safe-green);
            border-radius: 12px;
            padding: 16px 20px;
            margin-bottom: 20px;
        }

        .safe-banner h4 {
            color: var(--safe-green);
            font-size: 14px;
            font-weight: 700;
            display: flex;
            align-items: center;
            gap: 8px;
            margin-bottom: 8px;
        }

        /* Info Banner */
        .info-banner {
            background: var(--info-bg);
            border: 2px solid var(--info-blue);
            border-radius: 12px;
            padding: 16px 20px;
            margin-bottom: 20px;
        }

        .info-banner h4 {
            color: var(--info-blue);
            font-size: 14px;
            font-weight: 700;
            display: flex;
            align-items: center;
            gap: 8px;
            margin-bottom: 8px;
        }

        /* Grid Layout */
        .grid-2 {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(400px, 1fr));
            gap: 20px;
        }

        .grid-3 {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
        }

        /* Table Styles */
        .data-table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 16px;
        }

        .data-table th,
        .data-table td {
            padding: 14px 16px;
            text-align: left;
            border-bottom: 1px solid var(--neutral-border);
        }

        .data-table th {
            background: var(--neutral-bg);
            font-weight: 600;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            color: var(--text-secondary);
        }

        .data-table tr:hover {
            background: var(--neutral-bg);
        }

        .data-table .highlight {
            background: #fef3c7;
            font-weight: 600;
        }

        /* Medication Tags */
        .med-tag {
            display: inline-block;
            padding: 4px 12px;
            border-radius: 20px;
            font-size: 12px;
            font-weight: 600;
            margin: 4px;
        }

        .med-tag.glp1 {
            background: #dbeafe;
            color: #1e40af;
        }

        .med-tag.tirzepatide {
            background: #fce7f3;
            color: #9d174d;
        }

        /* Badge */
        .badge {
            display: inline-flex;
            align-items: center;
            gap: 4px;
            padding: 6px 12px;
            border-radius: 8px;
            font-size: 12px;
            font-weight: 600;
        }

        .badge-emergency {
            background: var(--emergency-red);
            color: white;
        }

        .badge-warning {
            background: var(--warning-orange);
            color: white;
        }

        .badge-safe {
            background: var(--safe-green);
            color: white;
        }

        .badge-info {
            background: var(--info-blue);
            color: white;
        }

        /* Section Hide/Show */
        .section {
            display: none;
        }

        .section.active {
            display: block;
            animation: fadeIn 0.3s ease;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }

        /* List Styles */
        .quick-list {
            list-style: none;
        }

        .quick-list li {
            padding: 12px 0;
            border-bottom: 1px solid var(--neutral-border);
            display: flex;
            align-items: flex-start;
            gap: 12px;
        }

        .quick-list li:last-child {
            border-bottom: none;
        }

        .quick-list .bullet {
            width: 8px;
            height: 8px;
            border-radius: 50%;
            margin-top: 8px;
            flex-shrink: 0;
        }

        .bullet-red { background: var(--emergency-red); }
        .bullet-green { background: var(--safe-green); }
        .bullet-blue { background: var(--info-blue); }
        .bullet-orange { background: var(--warning-orange); }

        /* Timeline */
        .timeline {
            position: relative;
            padding-left: 32px;
        }

        .timeline::before {
            content: '';
            position: absolute;
            left: 8px;
            top: 0;
            bottom: 0;
            width: 2px;
            background: var(--neutral-border);
        }

        .timeline-item {
            position: relative;
            padding-bottom: 24px;
        }

        .timeline-item::before {
            content: '';
            position: absolute;
            left: -28px;
            top: 4px;
            width: 14px;
            height: 14px;
            border-radius: 50%;
            background: var(--info-blue);
            border: 3px solid white;
            box-shadow: 0 0 0 2px var(--info-blue);
        }

        .timeline-item .time {
            font-size: 12px;
            font-weight: 600;
            color: var(--text-secondary);
            margin-bottom: 4px;
        }

        .timeline-item .content {
            background: var(--neutral-bg);
            padding: 12px 16px;
            border-radius: 8px;
            font-size: 14px;
        }

        /* Stat Box */
        .stat-box {
            background: linear-gradient(135deg, var(--info-blue) 0%, #0369a1 100%);
            color: white;
            padding: 20px;
            border-radius: 12px;
            text-align: center;
        }

        .stat-box .value {
            font-size: 32px;
            font-weight: 700;
            margin-bottom: 4px;
        }

        .stat-box .label {
            font-size: 12px;
            opacity: 0.9;
        }

        /* Side Effect Card */
        .side-effect-item {
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 14px 16px;
            background: var(--neutral-bg);
            border-radius: 10px;
            margin-bottom: 10px;
            transition: all 0.3s ease;
        }

        .side-effect-item:hover {
            background: #e2e8f0;
            transform: translateX(4px);
        }

        .side-effect-item .effect {
            font-weight: 500;
        }

        .side-effect-item .frequency {
            font-size: 12px;
            padding: 4px 10px;
            border-radius: 20px;
            font-weight: 600;
        }

        .freq-common {
            background: #fef3c7;
            color: #92400e;
        }

        .freq-rare {
            background: #fce7f3;
            color: #9d174d;
        }

        .freq-serious {
            background: var(--emergency-bg);
            color: var(--emergency-red);
        }

        /* Comparison Table */
        .comparison-row {
            display: grid;
            grid-template-columns: 200px 1fr 1fr;
            gap: 1px;
            background: var(--neutral-border);
            border-radius: 10px;
            overflow: hidden;
        }

        .comparison-cell {
            background: white;
            padding: 16px;
        }

        .comparison-cell.header {
            background: var(--neutral-bg);
            font-weight: 600;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            color: var(--text-secondary);
        }

        /* Responsive */
        @media (max-width: 768px) {
            .grid-2, .grid-3 {
                grid-template-columns: 1fr;
            }

            .header h1 {
                font-size: 22px;
            }

            .comparison-row {
                grid-template-columns: 1fr;
            }

            .data-table {
                font-size: 13px;
            }

            .data-table th,
            .data-table td {
                padding: 10px 12px;
            }
        }

        /* Print Styles */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .nav-tabs {
                display: none;
            }

            .section {
                display: block !important;
                page-break-inside: avoid;
            }

            .card {
                box-shadow: none;
                border: 1px solid #ddd;
            }
        }

        /* Tooltip */
        .tooltip {
            position: relative;
            cursor: help;
        }

        .tooltip::after {
            content: attr(data-tip);
            position: absolute;
            bottom: 100%;
            left: 50%;
            transform: translateX(-50%);
            background: var(--text-primary);
            color: white;
            padding: 8px 12px;
            border-radius: 6px;
            font-size: 12px;
            white-space: nowrap;
            opacity: 0;
            visibility: hidden;
            transition: all 0.3s ease;
            z-index: 100;
        }

        .tooltip:hover::after {
            opacity: 1;
            visibility: visible;
        }

        /* Scroll indicator */
        .scroll-hint {
            text-align: center;
            padding: 20px;
            color: var(--text-secondary);
            font-size: 13px;
        }

        /* Quick reference sidebar */
        .quick-ref {
            position: fixed;
            right: 20px;
            top: 50%;
            transform: translateY(-50%);
            background: white;
            border-radius: 12px;
            padding: 16px;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.1);
            z-index: 100;
            display: none;
        }

        @media (min-width: 1200px) {
            .quick-ref {
                display: block;
            }
        }

        .quick-ref-item {
            display: flex;
            align-items: center;
            gap: 8px;
            padding: 8px;
            border-radius: 6px;
            font-size: 12px;
            cursor: pointer;
            transition: all 0.3s ease;
        }

        .quick-ref-item:hover {
            background: var(--neutral-bg);
        }

        .quick-ref-item .dot {
            width: 10px;
            height: 10px;
            border-radius: 50%;
        }
    </style>
</head>
<body>
    <div class="container">
        <!-- Header -->
        <header class="header">
            <h1>GLP-1 & Tirzepatide Clinical Reference</h1>
            <p>Quick-scan guide for healthcare professionals ‚Ä¢ Based on NICE Guidelines & BNF 2024</p>
        </header>

        <!-- Navigation -->
        <nav class="nav-tabs">
            <div class="nav-tab active" data-section="overview">Overview</div>
            <div class="nav-tab" data-section="criteria">NICE Criteria</div>
            <div class="nav-tab" data-section="dosing">Dosing</div>
            <div class="nav-tab" data-section="side-effects">Side Effects</div>
            <div class="nav-tab" data-section="evidence">Evidence</div>
            <div class="nav-tab" data-section="emergency">Emergency</div>
        </nav>

        <!-- Section: Overview -->
        <section id="overview" class="section active">
            <div class="emergency-banner">
                <h3>‚ö†Ô∏è CRITICAL: MHRA Safety Update (Oct 2024)</h3>
                <ul>
                    <li><strong>GI side effects:</strong> Nausea, vomiting, diarrhea, constipation affect >1 in 10 patients</li>
                    <li><strong>Dehydration risk:</strong> Can lead to severe complications and hospitalization</li>
                    <li><strong>Always warn patients</strong> at initiation and each dose increase about side effects and hydration</li>
                    <li><strong>Hypoglycemia risk:</strong> Can occur even in non-diabetic patients, especially with insulin/SUs</li>
                </ul>
            </div>

            <div class="grid-2">
                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: #dbeafe;">üíä</div>
                        <h2>Medications Overview</h2>
                    </div>
                    <div style="margin-bottom: 16px;">
                        <span class="med-tag glp1">Liraglutide (Victoza/Saxenda)</span>
                        <span class="med-tag glp1">Semaglutide (Rybelsus/Ozempic/Wegovy)</span>
                        <span class="med-tag glp1">Dulaglutide</span>
                        <span class="med-tag glp1">Exenatide</span>
                        <span class="med-tag glp1">Lixisenatide</span>
                        <span class="med-tag tirzepatide">Tirzepatide (Mounjaro)</span>
                    </div>
                    <p style="font-size: 14px; color: var(--text-secondary);">
                        <strong>Tirzepatide</strong> is a dual GLP-1/GIP agonist with superior efficacy for both glycemic control and weight loss compared to GLP-1 monotherapy.
                    </p>
                </div>

                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: #dcfce7;">‚ö°</div>
                        <h2>Mechanism of Action</h2>
                    </div>
                    <ul class="quick-list">
                        <li>
                            <span class="bullet bullet-green"></span>
                            <div><strong>Insulin:</strong> Increased secretion and improved tissue sensitivity</div>
                        </li>
                        <li>
                            <span class="bullet bullet-green"></span>
                            <div><strong>Glucagon:</strong> Suppressed secretion (post-prandial hyperglycemia target)</div>
                        </li>
                        <li>
                            <span class="bullet bullet-blue"></span>
                            <div><strong>Gastric emptying:</strong> Slowed, promoting satiety</div>
                        </li>
                        <li>
                            <span class="bullet bullet-blue"></span>
                            <div><strong>Appetite:</strong> Increased satiety, reduced hunger</div>
                        </li>
                    </ul>
                </div>
            </div>

            <div class="grid-3">
                <div class="stat-box">
                    <div class="value">~2%</div>
                    <div class="label">Mean HbA1c reduction with tirzepatide</div>
                </div>
                <div class="stat-box">
                    <div class="value">8.5kg</div>
                    <div class="label">Mean weight loss with tirzepatide vs placebo</div>
                </div>
                <div class="stat-box">
                    <div class="value">12-18%</div>
                    <div class="label">Weight loss with GLP-1 mimetics</div>
                </div>
            </div>

            <div class="card" style="margin-top: 20px;">
                <div class="card-header">
                    <div class="icon" style="background: #fef3c7;">‚úÖ</div>
                    <h2>Key Advantages</h2>
                </div>
                <div class="grid-2" style="gap: 16px;">
                    <ul class="quick-list" style="margin: 0;">
                        <li>
                            <span class="bullet bullet-green"></span>
                            <div><strong>Low hypoglycemia risk</strong> (unless combined with insulin/SUs)</div>
                        </li>
                        <li>
                            <span class="bullet bullet-green"></span>
                            <div><strong>Cardioprotective</strong> - particularly in patients with CVD</div>
                        </li>
                    </ul>
                    <ul class="quick-list" style="margin: 0;">
                        <li>
                            <span class="bullet bullet-green"></span>
                            <div><strong>Renoprotective</strong> - mainly in patients with CKD</div>
                        </li>
                        <li>
                            <span class="bullet bullet-green"></span>
                            <div><strong>Weight loss</strong> - beneficial in obesity-related comorbidities</div>
                        </li>
                    </ul>
                </div>
            </div>
        </section>

        <!-- Section: NICE Criteria -->
        <section id="criteria" class="section">
            <div class="warning-banner">
                <h4>‚ö†Ô∏è IMPORTANT</h4>
                <p style="font-size: 14px;">NICE reserves GLP-1s and tirzepatide for use in patients with obesity due to cost considerations. US/European guidelines (less cost-sensitive) recommend wider use in CVD.</p>
            </div>

            <div class="grid-2">
                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: #dbeafe;">ü©∫</div>
                        <h2>Type 2 Diabetes - Glycemic Control</h2>
                    </div>
                    <div class="info-banner">
                        <h4>üìã NICE Criteria</h4>
                        <p style="font-size: 14px;">Use only if triple oral therapy not effective, tolerated, or contraindicated:</p>
                    </div>
                    <ul class="quick-list">
                        <li>
                            <span class="bullet bullet-blue"></span>
                            <div><strong>BMI ‚â•35 kg/m¬≤</strong> AND specific obesity-related medical problem</div>
                        </li>
                        <li>
                            <span class="bullet bullet-blue"></span>
                            <div><strong>BMI ‚â•32.5 kg/m¬≤</strong> if Asian, South Asian, Chinese, Middle Eastern, Black African or African-Caribbean family origin</div>
                        </li>
                        <li>
                            <span class="bullet bullet-orange"></span>
                            <div>Lower BMI threshold if weight loss would significantly help obesity-related comorbidity OR occupation makes insulin unsuitable</div>
                        </li>
                    </ul>
                </div>

                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: #fce7f3;">‚öñÔ∏è</div>
                        <h2>Weight Management</h2>
                    </div>
                    <table class="data-table">
                        <thead>
                            <tr>
                                <th>Medication</th>
                                <th>Prescribed By</th>
                                <th>BMI Criteria</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><span class="med-tag tirzepatide">Tirzepatide</span></td>
                                <td>Not restricted to specialist</td>
                                <td>‚â•35 kg/m¬≤</td>
                            </tr>
                            <tr>
                                <td><span class="med-tag glp1">Semaglutide</span></td>
                                <td>Not restricted to specialist</td>
                                <td>‚â•35 kg/m¬≤ (or 30-34.9 with CVD risk factors)</td>
                            </tr>
                            <tr>
                                <td><span class="med-tag glp1">Liraglutide</span></td>
                                <td>Specialist weight loss services only</td>
                                <td>‚â•35 kg/m¬≤</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
            </div>

            <div class="card">
                <div class="card-header">
                    <div class="icon" style="background: var(--emergency-bg);">üõë</div>
                    <h2>Stop Criteria</h2>
                </div>
                <div class="comparison-row">
                    <div class="comparison-cell header">Medication</div>
                    <div class="comparison-cell header">Criteria</div>
                    <div class="comparison-cell header">Duration</div>
                </div>
                <div class="comparison-row">
                    <div class="comparison-cell"><strong>GLP-1 mimetics</strong></div>
                    <div class="comparison-cell">Continue only if ‚â•11mmol/mol (1%) HbA1c fall AND ‚â•3% weight loss in first 6 months</div>
                    <div class="comparison-cell">Maximum 2 years</div>
                </div>
                <div class="comparison-row">
                    <div class="comparison-cell"><strong>Tirzepatide</strong></div>
                    <div class="comparison-cell">No specific 'stop' criteria</div>
                    <div class="comparison-cell">No limit on duration</div>
                </div>
            </div>
        </section>

        <!-- Section: Dosing -->
        <section id="dosing" class="section">
            <div class="emergency-banner">
                <h3>‚ö†Ô∏è CRITICAL: DKA Risk with Insulin</h3>
                <ul>
                    <li><strong>Beware possible DKA risk</strong> if used with insulin</li>
                    <li>DKA reported in T2DM patients on insulin and GLP-1s, especially after rapid insulin dose reduction</li>
                    <li>This risk MAY also apply to tirzepatide</li>
                    <li><strong>Action:</strong> Monitor closely when initiating/increasing dose, counsel patients on DKA symptoms</li>
                </ul>
            </div>

            <div class="card">
                <div class="card-header">
                    <div class="icon" style="background: #dcfce7;">üíâ</div>
                    <h2>Tirzepatide Dosing Schedule (All Indications)</h2>
                </div>
                <div class="info-banner">
                    <h4>üì¶ Formulation</h4>
                    <p style="font-size: 14px;">Pre-filled KwikPen: 2.5mg/5mg/7.5mg/10mg/12.5mg/15mg per 0.6ml. Each pen contains 4 doses. Keep refrigerated; can store at room temperature for up to 30 days.</p>
                </div>
                <div class="timeline">
                    <div class="timeline-item">
                        <div class="time">Week 1-4</div>
                        <div class="content"><strong>2.5mg once weekly</strong> - Starting dose</div>
                    </div>
                    <div class="timeline-item">
                        <div class="time">Week 5-8+</div>
                        <div class="content"><strong>5mg once weekly</strong> - Minimum 4 weeks at this dose</div>
                    </div>
                    <div class="timeline-item">
                        <div class="time">Week 9+</div>
                        <div class="content"><strong>Increase by 2.5mg</strong> every 4+ weeks as needed, up to 15mg maximum</div>
                    </div>
                </div>
                <div class="safe-banner" style="margin-top: 16px;">
                    <h4>üí° Key Points</h4>
                    <ul style="margin-left: 24px; font-size: 14px;">
                        <li>Long half-life (5 days) - weekly dosing</li>
                        <li>Steady state reached after 4 weeks</li>
                        <li>Slow up-titration minimizes GI side effects</li>
                    </ul>
                </div>
            </div>

            <div class="grid-2">
                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: #fef3c7;">‚ö†Ô∏è</div>
                        <h2>Cautions & Contraindications</h2>
                    </div>
                    <ul class="quick-list">
                        <li>
                            <span class="bullet bullet-orange"></span>
                            <div><strong>History of pancreatitis</strong> or severe GI disease - use with caution</div>
                        </li>
                        <li>
                            <span class="bullet bullet-orange"></span>
                            <div><strong>Delayed gastric emptying</strong> - especially after first dose</div>
                        </li>
                        <li>
                            <span class="bullet bullet-red"></span>
                            <div><strong>Pregnancy:</strong> Avoid - toxic in animal studies. Stop 1 month before trying to conceive.</div>
                        </li>
                        <li>
                            <span class="bullet bullet-orange"></span>
                            <div><strong>Breastfeeding:</strong> Avoid (limited data, but large molecular weight reduces milk secretion)</div>
                        </li>
                    </ul>
                </div>

                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: #dbeafe;">üíä</div>
                        <h2>Drug Interactions</h2>
                    </div>
                    <div class="warning-banner">
                        <h4>‚ö†Ô∏è Oral Drugs with Narrow Therapeutic Index</h4>
                        <p style="font-size: 14px; margin-top: 8px;">Monitor patients closely when starting/increasing tirzepatide dose due to delayed gastric emptying affecting absorption.</p>
                    </div>
                    <div class="info-banner">
                        <h4>üí° Oral Contraceptives</h4>
                        <p style="font-size: 14px;">SPC advises: For 4 weeks after initiation or dose increase, use non-oral or barrier methods (tirzepatide reaches steady state after 4 weeks).</p>
                    </div>
                </div>
            </div>
        </section>

        <!-- Section: Side Effects -->
        <section id="side-effects" class="section">
            <div class="emergency-banner">
                <h3>‚ö†Ô∏è GI Side Effects - Most Common</h3>
                <p style="font-size: 14px; margin-bottom: 12px;">These affect more than 1 in 10 patients. Usually non-serious but can lead to severe complications including hospitalization due to dehydration.</p>
                <ul>
                    <li><strong>Always warn patients</strong> at initiation and each dose increase</li>
                    <li><strong>Remind patients to keep well hydrated</strong></li>
                    <li>Slow dose titration helps minimize symptoms</li>
                </ul>
            </div>

            <div class="grid-2">
                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: #fef3c7;">üìä</div>
                        <h2>Common Side Effects</h2>
                    </div>
                    <div class="side-effect-item">
                        <span class="effect">Nausea</span>
                        <span class="frequency freq-common">Very Common (>1 in 10)</span>
                    </div>
                    <div class="side-effect-item">
                        <span class="effect">Vomiting</span>
                        <span class="frequency freq-common">Very Common (>1 in 10)</span>
                    </div>
                    <div class="side-effect-item">
                        <span class="effect">Diarrhea</span>
                        <span class="frequency freq-common">Very Common (>1 in 10)</span>
                    </div>
                    <div class="side-effect-item">
                        <span class="effect">Constipation</span>
                        <span class="frequency freq-common">Very Common (>1 in 10)</span>
                    </div>
                    <div class="side-effect-item">
                        <span class="effect">Dyspepsia</span>
                        <span class="frequency freq-common">Common</span>
                    </div>
                </div>

                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: var(--emergency-bg);">üî¥</div>
                        <h2>Rare but Serious Side Effects</h2>
                    </div>
                    <div class="side-effect-item">
                        <span class="effect">Pancreatitis</span>
                        <span class="frequency freq-serious">Rare but Serious</span>
                    </div>
                    <div class="side-effect-item">
                        <span class="effect">Gallstones</span>
                        <span class="frequency freq-serious">Rare but Serious</span>
                    </div>
                    <div class="side-effect-item">
                        <span class="effect">DKA (with insulin)</span>
                        <span class="frequency freq-serious">Serious Risk</span>
                    </div>
                    <div class="side-effect-item">
                        <span class="effect">Severe dehydration</span>
                        <span class="frequency freq-serious">Serious Risk</span>
                    </div>
                </div>
            </div>

            <div class="card">
                <div class="card-header">
                    <div class="icon" style="background: #fce7f3;">ü§∞</div>
                    <h2>Reproductive Safety</h2>
                </div>
                <div class="grid-2" style="gap: 16px;">
                    <div class="warning-banner">
                        <h4>üõë Contraindications</h4>
                        <ul style="margin-left: 20px; font-size: 14px; margin-top: 8px;">
                            <li>Avoid in pregnancy</li>
                            <li>Avoid while breastfeeding</li>
                            <li>Ensure adequate contraception in women of childbearing potential</li>
                        </ul>
                    </div>
                    <div class="info-banner">
                        <h4>‚è∞ Pre-conception Planning</h4>
                        <ul style="margin-left: 20px; font-size: 14px; margin-top: 8px;">
                            <li><strong>Semaglutide:</strong> Stop 2 months before trying to conceive</li>
                            <li><strong>Tirzepatide:</strong> Stop 1 month before trying to conceive</li>
                            <li><strong>Liraglutide:</strong> No washout period required</li>
                        </ul>
                    </div>
                </div>
            </div>
        </section>

        <!-- Section: Evidence -->
        <section id="evidence" class="section">
            <div class="grid-3">
                <div class="stat-box">
                    <div class="value">1.25-1.5%</div>
                    <div class="label">HbA1c reduction over 40 weeks (tirzepatide)</div>
                </div>
                <div class="stat-box">
                    <div class="value">7-10.5kg</div>
                    <div class="label">Weight loss over 40 weeks (tirzepatide vs placebo)</div>
                </div>
                <div class="stat-box">
                    <div class="value">44-62%</div>
                    <div class="label">MASH resolution with tirzepatide</div>
                </div>
            </div>

            <div class="grid-2">
                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: #dcfce7;">üìà</div>
                        <h2>Tirzepatide vs Semaglutide (Head-to-Head)</h2>
                    </div>
                    <div class="safe-banner">
                        <h4>üèÜ SURPASS-2 Trial (NEJM 2021)</h4>
                        <p style="font-size: 14px; margin-top: 8px;">Tirzepatide superior to semaglutide for both glycemic control and weight loss in T2DM.</p>
                    </div>
                    <div class="info-banner">
                        <h4>üìä Latest Evidence (NEJM 2025)</h4>
                        <p style="font-size: 14px; margin-top: 8px;">Head-to-head trial by tirzepatide manufacturer confirmed superior weight loss and cardiometabolic improvements vs semaglutide.</p>
                    </div>
                </div>

                <div class="card">
                    <div class="card-header">
                        <div class="icon" style="background: #dbeafe;">‚ù§Ô∏è</div>
                        <h2>Cardiovascular & Renal Benefits</h2>
                    </div>
                    <ul class="quick-list">
                        <li>
                            <span class="bullet bullet-green"></span>
                            <div><strong>CV benefits:</strong> Improved lipid profiles and blood pressure in SURPASS trials. SURPASS-CVOT trial ongoing for CV outcomes.</div>
                        </li>
                        <li>
                            <span class="bullet bullet-green"></span>
                            <div><strong>Renal benefits:</strong> Hints of benefits from trials. Full data pending.</div>
                        </li>
                        <li>
                            <span class="bullet bullet-blue"></span>
                            <div><strong>GLP-1s:</strong> Established cardioprotective and renoprotective effects, particularly in CVD and CKD.</div>
                        </li>
                    </ul>
                </div>
            </div>

            <div class="card">
                <div class="card-header">
                    <div class="icon" style="background: #fce7f3;">üåô</div>
                    <h2>Emerging Evidence: Sleep Apnea</h2>
                </div>
                <div class="grid-2" style="gap: 16px;">
                    <div class="info-banner">
                        <h4>üìã Trial Results (NEJM 2024)</h4>
                        <ul style="margin-left: 20px; font-size: 14px; margin-top: 8px;">
                            <li>~500 participants with obesity and sleep apnea</li>
                            <li>12-month follow-up</li>
                            <li>Apnea episodes reduced from ~50/h to 20-24 fewer/h</li>
                            <li>BMI reduced by ~17% vs placebo</li>
                        </ul>
                    </div>
                    <div class="safe-banner">
                        <h4>üìâ Blood Pressure Improvements</h4>
                        <ul style="margin-left: 20px; font-size: 14px; margin-top: 8px;">
                            <li>Systolic BP: -4 to -8 mmHg</li>
                            <li>Diastolic BP: -1 to -3 mmHg</li>
                            <li>Significant improvement in sleep-related outcomes</li>
                        </ul>
                    </div>
                </div>
            </div>

            <div class="card">
                <div class="card-header">
                    <div class="icon" style="background: #fef3c7;">üè•</div>
                    <h2>Metabolic Liver Disease (MASH)</h2>
                </div>
                <table class="data-table">
                    <thead>
                        <tr>
                            <th>Treatment</th>
                            <th>MASH Resolution (no fibrosis worsening)</th>
                            <th>Fibrosis Improvement</th>
                            <th>Duration</parameter>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><span class="med-tag tirzepatide">Tirzepatide 5mg</span></td>
                            <td>44%</td>
                            <td rowspan="3">~50% (little dose variation)</td>
                            <td rowspan="4">48 weeks</td>
                        </tr>
                        <tr>
                            <td><span class="med-tag tirzepatide">Tirzepatide 10mg</span></td>
                            <td>56%</td>
                        </tr>
                        <tr>
                            <td><span class="med-tag tirzepatide">Tirzepatide 15mg</span></td>
                            <td>62%</td>
                        </tr>
                        <tr>
                            <td>Placebo</td>
                            <td>10%</td>
                            <td>~30%</td>
                        </tr>
                    </tbody>
                </table>
                <div class="warning-banner" style="margin-top: 16px;">
                    <h4>‚ö†Ô∏è Note</h4>
                    <p style="font-size: 14px;">Trials were small. Positive results, but unknown what happens when treatment is stopped. Significant weight regain on stopping medication.</p>
                </div>
            </div>
        </section>

        <!-- Section: Emergency -->
        <section id="emergency" class="section">
            <div style="background: linear-gradient(135deg, #dc2626 0%, #b91c1c 100%); color: white; padding: 24px; border-radius: 16px; margin-bottom: 24px; box-shadow: 0 8px 32px rgba(220, 38, 38, 0.4);">
                <h2 style="font-size: 24px; margin-bottom: 16px; display: flex; align-items: center; gap: 12px;">
                    üö® Emergency Reference Guide
                </h2>
                <p style="opacity: 0.9;">Critical situations requiring immediate action</p>
            </div>

            <div class="grid-2">
                <div class="card" style="border-left: 4px solid var(--emergency-red);">
                    <div class="card-header">
                        <div class="icon" style="background: var(--emergency-bg);">ü§ï</div>
                        <h2 style="color: var(--emergency-red);">Pancreatitis</h2>
                    </div>
                    <div class="emergency-banner" style="margin: 0;">
                        <h3>Symptoms</h3>
                        <ul>
                            <li>Severe persistent abdominal pain (may radiate to back)</li>
                            <li>Nausea and vomiting</li>
                            <li>Fever, tachycardia</li>
                        </ul>
                    </div>
                    <div class="warning-banner" style="margin: 16px 0 0 0;">
                        <h4>Action</h4>
                        <p style="font-size: 14px;">STOP medication immediately. Refer for urgent assessment. Admit if severe.</p>
                    </div>
                </div>

                <div class="card" style="border-left: 4px solid var(--emergency-red);">
                    <div class="card-header">
                        <div class="icon" style="background: var(--emergency-bg);">ü©∏</div>
                        <h2 style="color: var(--emergency-red);">Diabetic Ketoacidosis (DKA)</h2>
                    </div>
                    <div class="emergency-banner" style="margin: 0;">
                        <h3>Risk Factors & Triggers</h3>
                        <ul>
                            <li>Concomitant insulin use</li>
                            <li>Rapid insulin dose reduction</li>
                            <li>Illness, surgery, trauma</li>
                        </ul>
                    </div>
                    <div class="warning-banner" style="margin: 16px 0 0 0;">
                        <h4>Action</h4>
                        <p style="font-size: 14px;">URGENT medical attention required. Check blood ketones if suspected. DKA can occur with normal or mildly elevated glucose.</p>
                    </div>
                </div>
            </div>

            <div class="grid-2">
                <div class="card" style="border-left: 4px solid var(--warning-orange);">
                    <div class="card-header">
                        <div class="icon" style="background: var(--warning-bg);">üíß</div>
                        <h2 style="color: var(--warning-orange);">Severe Dehydration</h2>
                    </div>
                    <ul class="quick-list">
                        <li>
                            <span class="bullet bullet-orange"></span>
                            <div><strong>Signs:</strong> Dry mouth, reduced urine output, dizziness, tachycardia, hypotension, confusion</div>
                        </li>
                        <li>
                            <span class="bullet bullet-orange"></span>
                            <div><strong>Cause:</strong> Persistent vomiting/diarrhea from GI side effects</div>
                        </li>
                        <li>
                            <span class="bullet bullet-red"></span>
                            <div><strong>Can lead to:</strong> Acute kidney injury, hospitalization</div>
                        </li>
                    </ul>
                    <div class="warning-banner" style="margin-top: 16px;">
                        <h4>Action</h4>
                        <p style="font-size: 14px;">Assess hydration status. Consider IV fluids if severe. Advise on oral rehydration. Consider dose reduction or temporary discontinuation.</p>
                    </div>
                </div>

                <div class="card" style="border-left: 4px solid var(--warning-orange);">
                    <div class="card-header">
                        <div class="icon" style="background: var(--warning-bg);">ü§∞</div>
                        <h2 style="color: var(--warning-orange);">Pregnancy Detection</h2>
                    </div>
                    <div class="emergency-banner" style="margin: 0;">
                        <h3>Immediate Action Required</h3>
                        <ul>
                            <li>STOP medication immediately if pregnancy confirmed or suspected</li>
                            <li>Toxic effects in animal studies</li>
                            <li>No adequate human data</li>
                        </ul>
                    </div>
                    <div class="info-banner" style="margin: 16px 0 0 0;">
                        <h4>Pre-conception</h4>
                        <p style="font-size: 14px;">Ensure adequate contraception. Stop tirzepatide 1 month, semaglutide 2 months before trying to conceive.</p>
                    </div>
                </div>
            </div>

            <div class="card">
                <div class="card-header">
                    <div class="icon" style="background: var(--emergency-bg);">‚ö†Ô∏è</div>
                    <h2 style="color: var(--emergency-red);">Illegal/Subs Counterfeit Drugs</h2>
                </div>
                <div class="warning-banner">
                    <h4>üö´ CRITICAL WARNING</h4>
                    <p style="font-size: 14px; margin-top: 8px;">MHRA advises patients about risks of obtaining GLP-1 drugs from unauthorized sources or for unauthorized indications. Counterfeit products may be ineffective or dangerous.</p>
                </div>
                <ul class="quick-list" style="margin-top: 16px;">
                    <li>
                        <span class="bullet bullet-red"></span>
                        <div><strong>Only prescribe from legitimate pharmacies/supply chain</strong></div>
                    </li>
                    <li>
                        <span class="bullet bullet-red"></span>
                        <div><strong>Verify patient sources if they report supply issues</strong></div>
                    </li>
                    <li>
                        <span class="bullet bullet-orange"></span>
                        <div><strong>Report suspected counterfeit products to MHRA</strong></div>
                    </li>
                </ul>
            </div>

            <div class="safe-banner">
                <h4>‚úÖ Quick Emergency Checklist</h4>
                <div class="grid-3" style="gap: 16px; margin-top: 12px;">
                    <div style="display: flex; align-items: center; gap: 8px;">
                        <span style="color: var(--safe-green); font-size: 20px;">‚úì</span>
                        <span style="font-size: 14px;">Stop medication if severe adverse reaction suspected</span>
                    </div>
                    <div style="display: flex; align-items: center; gap: 8px;">
                        <span style="color: var(--safe-green); font-size: 20px;">‚úì</span>
                        <span style="font-size: 14px;">Assess ABCDE if patient acutely unwell</span>
                    </div>
                    <div style="display: flex; align-items: center; gap: 8px;">
                        <span style="color: var(--safe-green); font-size: 20px;">‚úì</span>
                        <span style="font-size: 14px;">Check blood glucose and ketones if DKA suspected</span>
                    </div>
                    <div style="display: flex; align-items: center; gap: 8px;">
                        <span style="color: var(--safe-green); font-size: 20px;">‚úì</span>
                        <span style="font-size: 14px;">IV access and fluids if dehydrated</span>
                    </div>
                    <div style="display: flex; align-items: center; gap: 8px;">
                        <span style="color: var(--safe-green); font-size: 20px;">‚úì</span>
                        <span style="font-size: 14px;">Urgently refer if pancreatitis suspected</span>
                    </div>
                    <div style="display: flex; align-items: center; gap: 8px;">
                        <span style="color: var(--safe-green); font-size: 20px;">‚úì</span>
                        <span style="font-size: 14px;">Document and report adverse events via Yellow Card</span>
                    </div>
                </div>
            </div>
        </section>
    </div>

    <script>
        // Navigation functionality
        document.querySelectorAll('.nav-tab').forEach(tab => {
            tab.addEventListener('click', function() {
                // Remove active class from all tabs and sections
                document.querySelectorAll('.nav-tab').forEach(t => t.classList.remove('active'));
                document.querySelectorAll('.section').forEach(s => s.classList.remove('active'));
                
                // Add active class to clicked tab and corresponding section
                this.classList.add('active');
                const sectionId = this.getAttribute('data-section');
                document.getElementById(sectionId).classList.add('active');
            });
        });

        // Add smooth scroll behavior
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function(e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({
                        behavior: 'smooth'
                    });
                }
            });
        });

        // Add animation on scroll
        const observerOptions = {
            threshold: 0.1,
            rootMargin: '0px 0px -50px 0px'
        };

        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.style.opacity = '1';
                    entry.target.style.transform = 'translateY(0)';
                }
            });
        }, observerOptions);

        document.querySelectorAll('.card').forEach(card => {
            card.style.opacity = '0';
            card.style.transform = 'translateY(20px)';
            card.style.transition = 'opacity 0.5s ease, transform 0.5s ease';
            observer.observe(card);
        });

        // Add hover sound effect (optional, visual feedback instead)
        document.querySelectorAll('.card, .nav-tab, .side-effect-item').forEach(item => {
            item.addEventListener('mouseenter', function() {
                this.style.transition = 'all 0.3s ease';
            });
        });

        // Search functionality (optional enhancement)
        let searchTerm = '';
        document.addEventListener('keydown', function(e) {
            if (e.key === '/' && !e.target.matches('input, textarea')) {
                e.preventDefault();
                const search = prompt('Search for clinical information:');
                if (search) {
                    searchTerm = search.toLowerCase();
                    highlightSearchTerms();
                }
            }
        });

        function highlightSearchTerms() {
            if (!searchTerm) return;
            const textElements = document.querySelectorAll('p, li, td, th');
            textElements.forEach(el => {
                const text = el.textContent;
                if (text.toLowerCase().includes(searchTerm)) {
                    el.style.background = '#fef3c7';
                    el.style.padding = '2px 4px';
                    el.style.borderRadius = '4px';
                    setTimeout(() => {
                        el.style.background = 'transparent';
                        el.style.padding = '0';
                    }, 2000);
                }
            });
        }

        // Print functionality
        window.printClinicalRef = function() {
            window.print();
        };

        // Keyboard shortcuts
        document.addEventListener('keydown', function(e) {
            // Number keys 1-6 for quick navigation
            if (e.key >= '1' && e.key <= '6' && !e.target.matches('input, textarea')) {
                const tabs = document.querySelectorAll('.nav-tab');
                const index = parseInt(e.key) - 1;
                if (tabs[index]) {
                    tabs[index].click();
                }
            }
        });
    </script>
</body>
</html>
